Skip to content
Screener

Novavax NVAX Gross Profit

Gross Profit at other companies

Moderna logo
ModernaMRNA
$52M+126%
Merck & Co. logo
Merck & Co.MRK
$12.21B-0.3%
ALN
Alnylam PharmaceuticalsALNY
$992.69M+57.2%
Gilead Sciences logo
Gilead SciencesGILD
$6.22B+11.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$43.97M+167%

Other financials

Income statement

See full
Revenue$56.7M-76.3%
Operating income-$54.9M-154%
Net income-$53.4M-150%
EPS (diluted)-$0.32-152%

Balance sheet

See full
Cash & equivalents$191.5M-24.5%
Total debt$297.3M+413%
Total equity-$190.7M-607%
Total assets$955.6M-28.5%

Cash flow

See full
Operating cash flow-$72.8M+42.9%
CapEx$588.0K+11.6%
Free cash flow-$73.4M+42.7%

Valuation

See full
Market cap$1.27B+3.7%
Enterprise value$1.38B+33.6%
P/S3.1×+1.9×

Profitability

See full
Gross margin78.6%-9.6pp
Operating margin-56.6%-89.2pp
Net margin-59.9%-99.1pp
FCF margin-59%-61.5pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.3×0.0×

Where this comes from

Calculated from Novavax’s reported figures.

The source filing: Novavax’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:50 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001000694-26-000018

FAQ

What is Novavax's gross profit?
Novavax (NVAX) reported gross profit of $42.45M in Q2 2026.
How has Novavax's gross profit changed year-over-year?
Novavax's gross profit decreased by 81.0% year-over-year, from $223.92M to $42.45M.
What is the long-term trend for Novavax's gross profit?
Over 4 years (2021 to 2025), Novavax's gross profit has grown at a -2.2% compound annual growth rate (CAGR), from $1.15B to $1.05B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Novavax's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude